tiprankstipranks
Corvus Pharmaceuticals Inc (CRVS)
NASDAQ:CRVS

Corvus Pharmaceuticals (CRVS) Technical Analysis

483 Followers

Technical Sentiment

Overall Consensus
Neutral
8Bullish
4Neutral
10Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
Corvus Pharmaceuticals Inc’s (CRVS) Moving Averages Convergence Divergence (MACD) indicator is -0.06, suggesting Corvus Pharmaceuticals Inc is a Buy.
Corvus Pharmaceuticals Inc’s (CRVS) 20-Day exponential moving average is 1.89, while Corvus Pharmaceuticals Inc’s (CRVS) share price is $1.82, making it a Sell.
Corvus Pharmaceuticals Inc’s (CRVS) 50-Day exponential moving average is 1.93, while Corvus Pharmaceuticals Inc’s (CRVS) share price is $1.82, making it a Sell.

Corvus Pharmaceuticals (CRVS) Pivot Points

Jul 07, 2024, 09:21 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.68
1.73
1.75
1.80
1.82
1.87
1.89
Fibonacci
1.73
1.75
1.77
1.80
1.82
1.84
1.87
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Corvus Pharmaceuticals (CRVS) Moving Averages

Jul 07, 2024, 09:21 AM
Period
Simple
Exponential
MA5
1.81Buy
1.81Buy
MA10
1.81Buy
1.84Sell
MA20
1.92Sell
1.89Sell
MA50
1.95Sell
1.93Sell
MA100
1.94Sell
1.92Sell
MA200
1.79Buy
1.89Sell
Corvus Pharmaceuticals Inc’s (CRVS) 10-Day exponential moving average is 1.84, while Corvus Pharmaceuticals Inc’s (CRVS) share price is $1.82, making it a Sell.
Corvus Pharmaceuticals Inc’s (CRVS) 100-Day exponential moving average is 1.92, while Corvus Pharmaceuticals Inc’s (CRVS) share price is $1.82, making it a Sell.
Corvus Pharmaceuticals Inc’s (CRVS) stock price is $1.82 and Corvus Pharmaceuticals Inc’s (CRVS) 50-day simple moving average is 1.95, creating a Sell signal.
Corvus Pharmaceuticals Inc’s (CRVS) stock price is $1.82 and Corvus Pharmaceuticals Inc’s (CRVS) 100-day simple moving average is 1.94, creating a Sell signal.
Corvus Pharmaceuticals Inc’s (CRVS) stock price is $1.82 and Corvus Pharmaceuticals Inc’s (CRVS) 200-day simple moving average is 1.79, creating a Buy signal.

Corvus Pharmaceuticals (CRVS) Technical Indicators

Jul 07, 2024, 09:21 AM
Name
Value
Implied Action
RSI (14)
43.59
Neutral
STOCH (9,6)
17.33
Buy
STOCHRSI (14)
9.44
Buy
MACD (12,26)
-0.06
Buy
ADX (14)
21.53
Neutral
Williams %R
-84.44
Buy
CCI (14)
-77.97
Neutral
ATR (14)
0.14
-
Ultimate Oscillator
34.79
Neutral
ROC
-14.15
Sell
Corvus Pharmaceuticals Inc’s (CRVS) Relative Strength Index (RSI) is 43.59, creating a Neutral signal.
Corvus Pharmaceuticals Inc’s (CRVS) Trend Strength Indicator (ADX) is 21.53, creating a Neutral signal.
Corvus Pharmaceuticals Inc’s (CRVS) Commodity Channel Index (CCI) is -77.97, creating a Neutral signal.
Corvus Pharmaceuticals Inc’s (CRVS) Price Rate of Change (ROC) is -14.15, creating a Sell signal.

FAQ

Is CRVS a Buy, Hold, or Sell?
Based on CRVS’s technical indicators, CRVS is a Hold.
    What is CRVS’s RSI (14)?
    CRVS’s RSI (14) is 43.59, which suggests CRVS is a Neutral.
      What is CRVS’s MACD?
      CRVS’s MACD is -0.06, which suggests CRVS is a Buy.
        What is CRVS’s 5-day moving average?
        CRVS’s 5-day moving average is 1.81, which suggests CRVS is a Buy.
          What is CRVS’s 20-day moving average?
          CRVS 20-day moving average is 1.92, which suggests CRVS is a Sell.
            What is CRVS’s 50-day moving average?
            CRVS’s 50-day moving average is 1.95, which suggests CRVS is a Sell.
              What is CRVS’s 200-day moving average?
              CRVS’s 200-day moving average is 1.79, which suggests CRVS is a Buy.
                What is CRVS’s Williams % R (14)?
                CRVS’s Williams % R (14) is -84.44, which suggests CRVS is a Buy.
                  What is CRVS’s CCI (14)?
                  CRVS’s CCI (14) is -77.97, which suggests CRVS is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis